Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A beginner-friendly intro to world stock dividend ETFs, covering basics like yields, diversification, and how to pick your first fund.
23,029 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Five years into Citi CEO Jane Fraser’s tenure, a sweeping rebuild has shifted the bank from risk and tech bottlenecks...
Pope Leo XIV issues Magnifica Humanitas, framing AI as a modern social contract test that echoes the Industrial Revol...
Optics stocks jump mid-session as coherent advances 16%, lumentum lift the sector; Applied Optoelectronics also gains...
The Supreme Court voided emergency tariff powers, pushing the administration to a Section 301 strategy aimed at a dur...
Three fintech names sit on the radar as potential acquisition targets in 2026. This analysis weighs market cap, cash ...
A quiet international fund is flashing some of the strongest gains in 2026. Schwab’s international ETF has climbed sh...
A hospital stay can end with Medicare denying skilled nursing facility coverage if the stay is classified as observat...
A high-net-worth retiree in washington discovers that a single Social Security claiming choice could cut his lifetime...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
A single quarterly beat isn’t the whole story. Micron’s latest results point to a multi-decade growth thesis that goe...
U.S. stocks opened the second half of 2026 with a cautious tone as chip stock profit-taking cooled a brisk first half...